A widely used hospital antibiotic may carry a small but potentially important mortality risk compared with similar drugs, ...
Amazon S3 on MSN
Common hospital antibiotic linked to higher death risk
A new global study published in JAMA Network Open found that cefepime, a commonly used antibiotic for treating pneumonia, ...
Daily Voice on MSN
Antibiotic study raises death risk concerns: What you should know
A widely used hospital antibiotic is drawing renewed scrutiny after a major research review raised concerns about patients’ survival. The drug is cefepime, used to treat serious bacterial infections.
A widely used hospital antibiotic is associated with a higher risk of death compared with other drugs in the same class, ...
Using data from 110 clinical trials that included more than 22,600 patients, both children and adults, researchers compared ...
More than 500,000 Medicare enrollees signed up for the $50 GLP-1 Bridge in two months what it means for eligibility, costs, and coverage after 2027. New Public Charge Rule Takes Effect Friday, Letting ...
In the phase 3 ENHANCE-1 trial, Zaynich demonstrated an 89% composite response rate compared with 68.4% for meropenem. Zaynich is a combination of cefepime, a cephalosporin antibacterial, and ...
What Is Zaynich, and Why Does It Matter? Zaynich (cefepime and zidebactam) is an intravenous (IV) antibiotic that is FDA-approved for adults with complicated urinary tract infections (cUTIs) that are ...
SHORT HILLS, N.J., June 1, 2026 /PRNewswire/ -- Wockhardt today announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepime and zidebactam), a novel intravenous ...
ZAYNICH is a multi-penicillin-binding protein targeting combination of the 4th generation cephalosporin cefepime and zidebactam working synergistically against the most challenging multidrug-resistant ...
The association between acute kidney injury (AKI) and the concomitant use of vancomycin with piperacillin-tazobactam (VPT), meropenem (VM), cefepime (VC), or monotherapy with vancomycin or ...
Please provide your email address to receive an email when new articles are posted on . A 42-year-old man presented to the emergency department with complaints of difficulty ambulating, fatigue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results